CI vs. CTAS

Last updated Apr 1, 2026

Compare and contrast key facts about Cigna Corporation (CI) and Cintas Corporation (CTAS).

Performance

CI vs. CTAS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cigna Corporation (CI) and Cintas Corporation (CTAS). The values are adjusted to include any dividend payments, if applicable.

CI vs. CTAS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CI Cigna Corporation	-2.55%	1.72%	-6.27%	-7.97%	46.68%	12.29%	1.83%	7.70%	-6.46%	52.29%
CTAS Cintas Corporation	-9.86%	3.78%	22.24%	34.82%	2.97%	26.51%	32.74%	61.73%	9.04%	36.32%

Fundamentals

Market Cap CI : $70.94B CTAS : $68.81B
EPS CI : $22.28 CTAS : $4.75
PE Ratio CI : 11.97 CTAS : 35.63
PEG Ratio CI : 0.69 CTAS : 2.50
PS Ratio CI : 0.26 CTAS : 6.26
PB Ratio CI : 1.70 CTAS : 14.37
Total Revenue (TTM) CI : $274.95B CTAS : $11.03B
Gross Profit (TTM) CI : $25.99B CTAS : $1.33B
EBITDA (TTM) CI : $12.17B CTAS : $2.66B

Returns By Period

In the year-to-date period, CI achieves a -2.55% return, which is significantly higher than CTAS's -9.86% return. Over the past 10 years, CI has underperformed CTAS with an annualized return of 7.90%, while CTAS has yielded a comparatively higher 23.61% annualized return.

CI

• 1D: 3.36%
• 1M: -7.45%
• YTD: -2.55%
• 6M: -6.43%
• 1Y: -17.21%
• 3Y*: 3.35%
• 5Y*: 3.84%
• 10Y*: 7.90%

CTAS

• 1D: 0.28%
• 1M: -15.91%
• YTD: -9.86%
• 6M: -17.21%
• 1Y: -17.00%
• 3Y*: 14.50%
• 5Y*: 15.26%
• 10Y*: 23.61%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

CI vs. CTAS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CI

CI Risk / Return Rank: 20
CI Sharpe Ratio Rank: 19
CI Sortino Ratio Rank: 20
CI Omega Ratio Rank: 18
CI Calmar Ratio Rank: 23
CI Martin Ratio Rank: 21

CTAS

CTAS Risk / Return Rank: 14
CTAS Sharpe Ratio Rank: 9
CTAS Sortino Ratio Rank: 11
CTAS Omega Ratio Rank: 12
CTAS Calmar Ratio Rank: 23
CTAS Martin Ratio Rank: 16

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CI vs. CTAS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cigna Corporation (CI) and Cintas Corporation (CTAS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CI	CTAS	Difference
Sharpe ratio Return per unit of total volatility	-0.52	-0.80	+0.28
Sortino ratio Return per unit of downside risk	-0.49	-1.02	+0.53
Omega ratio Gain probability vs. loss probability	0.92	0.87	+0.05
Calmar ratio Return relative to maximum drawdown	-0.59	-0.60	+0.01
Martin ratio Return relative to average drawdown	-1.14	-1.31	+0.17
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CI vs. CTAS - Sharpe Ratio Comparison

The current CI Sharpe Ratio is -0.52, which is higher than the CTAS Sharpe Ratio of -0.80. The chart below compares the historical Sharpe Ratios of CI and CTAS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CI	CTAS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.52	-0.80	+0.28
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.14	0.68	-0.55
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.26	0.89	-0.64
Sharpe Ratio (All Time) Calculated using the full available price history	0.34	0.52	-0.18

Correlation

The correlation between CI and CTAS is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CI vs. CTAS - Dividend Comparison

CI's dividend yield for the trailing twelve months is around 2.28%, more than CTAS's 1.03% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CI Cigna Corporation	2.28%	2.19%	2.03%	1.64%	1.35%	1.74%	0.02%	0.02%	0.02%	0.02%	0.03%	0.03%
CTAS Cintas Corporation	1.03%	0.89%	0.80%	0.83%	0.93%	0.77%	0.99%	0.95%	1.22%	1.04%	1.15%	1.15%

Drawdowns

CI vs. CTAS - Drawdown Comparison

The maximum CI drawdown since its inception was -84.34%, which is greater than CTAS's maximum drawdown of -65.32%. Use the drawdown chart below to compare losses from any high point for CI and CTAS.

Drawdown Indicators

	CI	CTAS	Difference
Max Drawdown Largest peak-to-trough decline	-84.34%	-65.32%	-19.02%
Max Drawdown (1Y) Largest decline over 1 year	-27.41%	-26.72%	-0.69%
Max Drawdown (5Y) Largest decline over 5 years	-32.10%	-26.72%	-5.38%
Max Drawdown (10Y) Largest decline over 10 years	-42.47%	-48.38%	+5.91%
Current Drawdown Current decline from peak	-25.07%	-25.20%	+0.13%
Average Drawdown Average peak-to-trough decline	-18.81%	-14.99%	-3.82%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.19%	12.22%	+1.97%

Volatility

CI vs. CTAS - Volatility Comparison

Cigna Corporation (CI) and Cintas Corporation (CTAS) have volatilities of 8.29% and 7.96%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CI	CTAS	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.29%	7.96%	+0.33%
Volatility (6M) Calculated over the trailing 6-month period	27.62%	14.35%	+13.27%
Volatility (1Y) Calculated over the trailing 1-year period	33.11%	21.38%	+11.73%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	28.13%	22.49%	+5.64%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	30.71%	26.52%	+4.19%

Financials

CI vs. CTAS - Profitability Comparison

The chart below illustrates the profitability comparison between Cigna Corporation and Cintas Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Cigna Corporation reported a gross profit of 5.55B and revenue of 72.47B. Therefore, the gross margin over that period was 7.7%.

CTAS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Cintas Corporation reported a gross profit of -2.78B and revenue of 2.84B. Therefore, the gross margin over that period was -97.8%.

CI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Cigna Corporation reported an operating income of 2.15B and revenue of 72.47B, resulting in an operating margin of 3.0%.

CTAS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Cintas Corporation reported an operating income of 659.90M and revenue of 2.84B, resulting in an operating margin of 23.2%.

CI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Cigna Corporation reported a net income of 1.23B and revenue of 72.47B, resulting in a net margin of 1.7%.

CTAS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Cintas Corporation reported a net income of 502.50M and revenue of 2.84B, resulting in a net margin of 17.7%.